Insmed
INSM
#542
Rank
โ‚น3.908 T
Marketcap
โ‚น18,327
Share price
-0.51%
Change (1 day)
187.29%
Change (1 year)

Earnings for Insmed (INSM)

Earnings in 2025 (TTM): -โ‚น95.42 Billion

According to Insmed's latest financial reports the company's current earnings are โ‚น0.44 Billion. In 2024 the company made an earning of -โ‚น74.55 Billion a decrease over its 2023 earnings that were of -โ‚น60.26 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insmed from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น95.42 Billion28%
2024 -โ‚น74.55 Billion23.71%
2023 -โ‚น60.26 Billion45.77%
2022 -โ‚น41.34 Billion15.83%
2021 -โ‚น35.7 Billion50.19%
2020 -โ‚น23.77 Billion16.4%
2019 -โ‚น20.42 Billion-23.9%
2018 -โ‚น26.83 Billion59.35%
2017 -โ‚น16.84 Billion8.52%
2016 -โ‚น15.52 Billion47.25%
2015 -โ‚น10.54 Billion34.53%
2014 -โ‚น7.84 Billion58.83%
2013 -โ‚น4.94 Billion35.14%
2012 -โ‚น3.65 Billion-31.92%
2011 -โ‚น5.36 Billion854.92%
2010 -โ‚น0.57 Billion-105.22%
2009 โ‚น10.74 B-905.06%
2008 -โ‚น1.34 Billion-27.31%
2007 -โ‚น1.84 Billion-62.41%
2006 -โ‚น4.89 Billion98.19%
2005 -โ‚น2.47 Billion0.03%
2004 -โ‚น2.47 Billion159.07%
2003 -โ‚น0.96 Billion-69.31%
2002 -โ‚น3.1 Billion
2000 -โ‚น2.8 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sarepta Therapeutics
SRPT
-โ‚น22.66 Billion-77.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น1.475 T-1,591.36%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
โ‚น888.12 B-997.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
โ‚น0.39 B-100.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-โ‚น2.09 Billion-97.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚น400.80 B-505.24%๐Ÿ‡บ๐Ÿ‡ธ USA